Source: DGNews  |  Posted 8 years ago

By Paula Moyer

PRAGUE, CZECH REPULIC -- October 3, 2003 -- Patients with schizophrenia can switch safely from oral olanzapine to risperidone in a long-acting injectable formulation and experience some improvement of symptoms.

"Long-acting risperidone was well tolerated in patients [who] switched from oral olanzapine," said Robert Jones, MD, a researcher with the medical affairs department of Janssen Pharmaceutica, Titusville, New Jersey, United States. Dr. Jones noted that improvement seen following the switch may be due to poor compliance with the oral formulation. Janssen manufacturers risperidone under the tradename Risperdal